ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PVLA vs XNCR // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Palvella Therapeutics Inc. (NASDAQ) VS. Xencor Inc. (NASDAQ) • 15-METRIC TALLY: PVLA 2 — XNCR 3
■ METRIC PARITY
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PVLA VS. XNCR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PVLA XNCR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -27.90% -21.30% -6.60 XNCR /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -1.14% -6.37% +5.23 PVLA /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 13.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.32 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 XNCR /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.5 68.0 -8.42 XNCR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.18B $2.17B $12.2M PVLA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PVLA REV XNCR REV PVLA GROSS % XNCR GROSS % PVLA FCF XNCR FCF
FY 2025 $0 $125.6M — — -$25.0M -$138.3M
FY 2024 $0 $110.5M — — -$10.8M -$208.3M
FY 2023 $42.8M $174.6M — — -$13.7M -$77.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PVLA // BETA —
XNCR // BETA —